These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15167927)

  • 1. Fine-tuning PU.1.
    Stirewalt DL
    Nat Genet; 2004 Jun; 36(6):550-1. PubMed ID: 15167927
    [No Abstract]   [Full Text] [Related]  

  • 2. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
    Inomata M; Takahashi S; Harigae H; Kameoka J; Kaku M; Sasaki T
    Leuk Res; 2006 Jun; 30(6):659-64. PubMed ID: 16271760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
    Suraweera N; Meijne E; Moody J; Carvajal-Carmona LG; Yoshida K; Pollard P; Fitzgibbon J; Riches A; van Laar T; Huiskamp R; Rowan A; Tomlinson IP; Silver A
    Oncogene; 2005 May; 24(22):3678-83. PubMed ID: 15750630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Dec; 10(6):456-7. PubMed ID: 17157786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
    Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG
    Nat Genet; 2004 Jun; 36(6):624-30. PubMed ID: 15146183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing PU.1 activity during hematopoiesis.
    Back J; Allman D; Chan S; Kastner P
    Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
    DeKoter RP; Kamath MB; Houston IB
    Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
    Dakic A; Wu L; Nutt SL
    Trends Immunol; 2007 Mar; 28(3):108-14. PubMed ID: 17267285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
    Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
    Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes.
    Kwok JC; Perdomo J; Chong BH
    J Cell Biochem; 2007 Aug; 101(6):1456-74. PubMed ID: 17340619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemogenesis in heterozygous PU.1 knockout mice.
    Genik PC; Vyazunova I; Steffen LS; Bacher JW; Bielefeldt-Ohmann H; McKercher S; Ullrich RL; Fallgren CM; Weil MM; Ray FA
    Radiat Res; 2014 Sep; 182(3):310-5. PubMed ID: 25076114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
    Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
    Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.